ArticleCancer science2021
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma.
Yuta Kodama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleCancer science2021
Yuta Kodama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.